Literature DB >> 18541903

Overview of HIV.

Nancy Klimas1, Anne O'Brien Koneru, Mary Ann Fletcher.   

Abstract

This article provides an overview and reviews the HIV pandemic, the basic biology and immunology of the virus (e.g., genetic diversity of HIV and the viral life cycle), the phases of disease progression, modes of HIV transmission, HIV testing, immune response to the infection, and current therapeutic strategies. HIV is occurring in epidemic proportions, especially in Sub-Saharan Africa. In the US, men who have sex with men account for over half of AIDS diagnoses; racial and ethnic minorities are disproportionally affected. Factors influencing the progression and severity of HIV infection include type of immune response, coinfection (e.g., another sexually transmitted infection, including hepatitis B or C), age and behavioral and psychosocial factors. Antiretroviral therapies can achieve reduction in blood levels of the HIV virus below the limits of detection by current technology. However, effective treatment requires adherence to therapy. Patient failure to adhere to treatment regimens results in detectible circulating virus and in HIV disease progression, and is the primary cause of drug resistance. In addition to research on the immunology and virology of the disease, other studies focus on behavioral and psychosocial factors that may affect medication adherence and risk behaviors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18541903     DOI: 10.1097/PSY.0b013e31817ae69f

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  13 in total

Review 1.  The assessment of complementary and alternative medicine use among individuals with HIV: a systematic review and recommendations for future research.

Authors:  Ashli Owen-Smith; Lara DePadilla; Ralph DiClemente
Journal:  J Altern Complement Med       Date:  2011-09       Impact factor: 2.579

2.  Using the Millon Behavioral Medicine Diagnostic (MBMD) to evaluate the need for mental health services in association with biomarkers of disease status among HIV positive men and women.

Authors:  Caitlin Burbridge; Dean G Cruess; Michael H Antoni; Sarah Meagher
Journal:  J Clin Psychol Med Settings       Date:  2011-03

Review 3.  Mother-to-child transmission (MTCT) of HIV and drugs of abuse in post-highly active antiretroviral therapy (HAART) era.

Authors:  Vishnudutt Purohit; Rao S Rapaka; David Shurtleff
Journal:  J Neuroimmune Pharmacol       Date:  2010-09-14       Impact factor: 4.147

4.  A randomized controlled trial of mindfulness-based stress reduction to manage affective symptoms and improve quality of life in gay men living with HIV.

Authors:  Bill Gayner; Mary Jane Esplen; Peter DeRoche; Jiahui Wong; Scott Bishop; Lynn Kavanagh; Kate Butler
Journal:  J Behav Med       Date:  2011-05-20

Review 5.  Atazanavir: a review of its use in the management of HIV-1 infection.

Authors:  Katherine F Croom; Sohita Dhillon; Susan J Keam
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

6.  Transportation-related barriers to care among African American women living with HIV/AIDS: "What you getting out of the cab for?"

Authors:  Shenell D Evans; Bryman E Williams
Journal:  Online J Rural Urban Res       Date:  2013

7.  Correlates of posttraumatic growth among African Americans living with HIV/AIDS in Mississippi.

Authors:  Shenell D Evans; Bryman E Williams; Cheng-Shiun Leu
Journal:  Online J Rural Urban Res       Date:  2013

8.  The level of DING proteins is increased in HIV-infected patients: in vitro and in vivo studies.

Authors:  Ahmed Djeghader; Gerard Aragonès; Nune Darbinian; Mikael Elias; Daniel Gonzalez; Anabel García-Heredia; Raúl Beltrán-Debón; Rafal Kaminski; Guillaume Gotthard; Julien Hiblot; Anna Rull; Olivier Rohr; Christian Schwartz; Carlos Alonso-Villaverde; Jorge Joven; Jordi Camps; Eric Chabriere
Journal:  PLoS One       Date:  2012-03-09       Impact factor: 3.240

Review 9.  Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors.

Authors:  Erik Serrao; Srinivas Odde; Kavya Ramkumar; Nouri Neamati
Journal:  Retrovirology       Date:  2009-03-05       Impact factor: 4.602

10.  Escherichia coli-expressed near full length HIV-1 envelope glycoprotein is a highly sensitive and specific diagnostic antigen.

Authors:  Sheikh M Talha; Satish Kumar Nemani; Teppo Salminen; Sushil Kumar; Sathyamangalam Swaminathan; Tero Soukka; Kim Pettersson; Navin Khanna
Journal:  BMC Infect Dis       Date:  2012-11-27       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.